A case of eribulin mesylate and demyelinating polyneuropathy with myokymic discharges

Muscle and Nerve

Volumn 53, Issue 1, 2016, Pages 151-152

  Peyronnard, Caroline ^a   Charpentier, Danielle ^a   Botez, Stephan Alcaz ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERIBULIN; FURAN DERIVATIVE; KETONE;

ADULT; BONE METASTASIS; BREAST CANCER; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG WITHDRAWAL; ELECTRODIAGNOSIS; FEMALE; HUMAN; LETTER; LIVER METASTASIS; LUNG METASTASIS; MULTIPLE CYCLE TREATMENT; MYOKYMIA; NERVE CONDUCTION; PRIORITY JOURNAL; COMPLICATION; DEMYELINATING DISEASES; POLYNEUROPATHIES;

ADULT; DEMYELINATING DISEASES; FEMALE; FURANS; HUMANS; KETONES; MYOKYMIA; POLYNEUROPATHIES;

EID: 84954385262     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24890     Document Type: Letter

References (6)

1. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society--First Revision. J Peripher Nerv Syst 2010;15:1-9.
2. Jain S, Cigler T. Eribulin mesylate in the treatment of metastatic breast cancer. Biologics 2012;6:21-29.
3. Dybdal-Hargreaves NF, Risinger AL, Mooberry SL. Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent. Clin Cancer Res 2015;21:2445-2452.
4. Cortes J, O'Shaughnessy J, Loesch D, Blum JL, Vahdat LT, Petrakova K, et al; EMBRACE (Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389) investigators. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. Lancet 2011;377:914-923.
5. Gutmann L. AAEM minimonograph #37: facial and limb myokymia. Muscle Nerve 1991;14:1043-1049.
6. Varela H, Rubin DI. Facial and trigeminal neuropathies as the initial manifestation of chronic inflammatory demyelinating polyradiculopathy. J Clin Neuromuscul Dis 2009;10:194-198.